Preliminary research suggests that use of a type of molecular imaging procedure may have the ability to detect the presence of beta-amyloid in the brains of individuals during life, a biomarker that is identified during autopsy to confirm a diagnosis of Alzheimer's disease, according to a new study.
Jan 18, 2011 12:00 AM
—
www.sciencedaily.com